Complete Filing Data
Alzamend Neuro, Inc. reported Stockholders Equity of $3.05 million for FY2023.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Alzamend Neuro, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income * | -$4.5M | -$9.9M | -$14.9M | -$12.4M | -$5.0M | -$4.4M |
| Research And Development Expense | $1.4M | $6.5M | $7.4M | $5.2M | $1.3M | $1.1M |
| Operating Income Loss | -$4.5M | -$9.9M | -$14.9M | -$12.3M | -$5.0M | -$4.4M |
| Nonoperating Income Expense | -$18.0K | -$10.1K | -$7.7K | -$42.5K | -$94.7K | $13.9K |
| General And Administrative Expense | $3.1M | $3.5M | $7.4M | $7.1M | $3.6M | $3.4M |
| Interest Expense | $18.0K | $10.1K | $7.7K | $46.5K | $142.4K | |
| Operating Expenses | $4.5M | $9.9M | $14.9M | |||
| Net Income Loss Available To Common Stockholders Basic | -$5.1M | -$9.9M | ||||
| Interest Expense Related Party | $16.4K | |||||
| Interest Income Expense Net | $1.7K | $13.9K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q1 2021 | Q4 2020 | Q3 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$1.0M | -$2.7M | -$1.0M | -$1.4M | -$974.4K | -$2.7M | -$2.9M | -$3.5M | -$5.4M | -$3.1M | -$3.0M | -$2.6M | -$3.6M | -$2.3M | -$1.1M | -$1.4M | -$1.3M |
| Research And Development Expense | $176.3K | $1.7M | $447.1K | $311.1K | $206.6K | $1.9M | $2.0M | $2.4M | $2.9M | $1.5M | $1.4M | $873.7K | $1.8M | $916.4K | $234.3K | $474.9K | $308.8K |
| Operating Income Loss | -$998.1K | -$2.7M | -$1.0M | -$1.4M | -$962.4K | -$2.7M | -$2.9M | -$3.5M | -$5.4M | -$3.1M | -$3.0M | -$2.6M | -$3.6M | -$2.3M | -$1.1M | -$1.3M | -$1.3M |
| Nonoperating Income Expense | -$2.6K | -$2.5K | -$2.0K | -$3.5K | -$12.0K | -$2.5K | -$4.3K | -$1.8K | -$2.1K | -$3.6K | -$1.5K | -$16.3K | -$16.0K | -$13.6K | -$3.2K | -$56.2K | $1.6K |
| General And Administrative Expense | $821.8K | $959.3K | $590.3K | $1.0M | $755.8K | $751.2K | $904.9K | $1.2M | $2.5M | $1.6M | $1.7M | $1.7M | $1.8M | $1.4M | $881.4K | $823.0K | $1.0M |
| Interest Expense | $2.6K | $2.5K | $2.0K | $3.5K | $12.0K | $2.5K | $4.3K | $1.8K | $2.1K | $3.6K | $1.5K | $16.3K | $16.0K | $13.6K | $57.4K | $50.7K | $151.00 |
| Operating Expenses | $998.1K | $2.7M | $1.0M | $1.4M | $962.4K | $2.7M | $2.9M | $3.5M | $5.4M | $3.1M | $3.0M | ||||||
| Net Income Loss Available To Common Stockholders Basic | -$1.0M | -$1.4M | -$2.9M | ||||||||||||||
| Interest Expense Related Party | $8.3K | $5.5K | |||||||||||||||
| Interest Income Expense Net | $1.7K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $4.0M | -$2.6M | $3.0M | $13.4M | $2.0M | $821.7K | $316.9K |
| Cash And Cash Equivalents At Carrying Value | $376.0K | $5.1M | $14.1M | $90.3K | $42.6K | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $5.1M | $14.1M | $1.9M | ||||
| Retained Earnings Accumulated Deficit | -$54.0M | -$44.1M | -$29.2M | -$16.8M | -$11.8M | ||
| Prepaid Expense And Other Assets Current | $79.2K | $447.6K | $349.7K | $983.3K | $1.6M | ||
| Liabilities And Stockholders Equity | $631.6K | $5.9M | $14.5M | $2.9M | $1.8M | ||
| Common Stock Value | $8.00 | $65.00 | $9.5K | $6.7K | $6.5K | ||
| Assets Current | $455.2K | $5.8M | $14.4M | $2.9M | $1.8M | ||
| Assets | $631.6K | $5.9M | $14.5M | $2.9M | $1.8M | ||
| Accounts Payable Current | $2.9M | $1.2M | $503.6K | $929.6K | |||
| Liabilities | $3.2M | $2.9M | $1.2M | $899.6K | |||
| Property Plant And Equipment Net | $176.3K | $79.8K | $102.9K | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $3.6M | -$4.8M | -$8.9M | $12.1M | |||
| Note Receivable For Common Stock Related Party | -$14.9M | -$14.9M | -$14.9M | -$15.0M | |||
| Liabilities Current | $1.2M | $899.6K | $992.3K | ||||
| Amortization Of Debt Discount Premium | $9.3K | $714.00 | $12.8K | $124.0K | |||
| Issuance Of Common Stock For Cash Net Of Issuance Costs | $2.7M | $1.3M | |||||
| Cash And Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $1.8M | $47.7K | |||||
| Issuance Of Preferred Stock For Cash Net Of Issuance Costs | $7.7M | ||||||
| Fair Value Of Warrants Issued In Connection With Convertible Notes Payable Related Party | $14.3K | ||||||
| Convertible Notes Payable | $335.3K | ||||||
| Preferred Stock Value | $75.00 | $75.00 | |||||
| Issuance Of Common Stock For Related Party Payable | $989.3K | ||||||
| Gains Losses On Extinguishment Of Debt | $4.0K | $62.4K | |||||
| Accounts Payable And Accrued Liabilities Current | $2.9M | ||||||
| Notes Payable Current | $300.7K | ||||||
| Issuance Of Preferred Stock For Cash | $2.1M | ||||||
| Issuance Of Common Stock For Cash | $1.3M | ||||||
| Fair Value Of Warrants Issued In Connection With Series Convertible Preferred Stock | $1.6M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $4.4M | $5.3M | $4.0M | $3.4M | $3.8M | -$1.2M | -$2.6M | -$4.3M | -$2.7M | -$112.9K | $5.9M | $8.8M | $11.2M | $13.4M | $12.0M | $13.0M | $15.3M | -$1.3M | -$666.8K | $25.9K | ||
| Cash And Cash Equivalents At Carrying Value | $4.4M | $5.6M | $3.9M | $3.4M | $4.1M | $1.2M | $282.9K | $200.1K | $1.7M | $7.4M | $9.2M | $11.5M | $11.8M | $13.6M | $15.6M | $1.9M | $40.7K | $5.9K | $63.1K | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $5.6M | $3.9M | $3.4M | $4.1M | $1.2M | $376.0K | $282.9K | $200.1K | $1.7M | $7.4M | $9.2M | $11.5M | $11.8M | |||||||||
| Retained Earnings Accumulated Deficit | -$62.2M | -$61.2M | -$58.5M | -$57.4M | -$56.4M | -$55.0M | -$53.2M | -$50.5M | -$47.6M | -$40.8M | -$35.3M | -$32.2M | -$25.3M | -$22.8M | -$19.2M | -$19.2M | ||||||
| Prepaid Expense And Other Assets Current | $272.0K | $308.0K | $228.7K | $589.2K | $673.7K | $222.2K | $310.7K | $581.8K | $718.2K | $546.3K | $409.6K | $587.5K | $638.8K | $928.2K | $1.2M | |||||||
| Liabilities And Stockholders Equity | $5.1M | $6.3M | $4.6M | $4.2M | $5.0M | $1.7M | $782.6K | $983.6K | $2.6M | $8.5M | $10.4M | $12.2M | $12.4M | $14.5M | $16.8M | |||||||
| Common Stock Value | $380.00 | $314.00 | $78.00 | $580.00 | $523.00 | $86.00 | $662.00 | $647.00 | $9.7K | $9.6K | $9.5K | $9.5K | $9.0K | $8.9K | $8.7K | |||||||
| Assets Current | $4.7M | $5.9M | $4.2M | $3.9M | $4.8M | $1.4M | $593.6K | $781.9K | $2.4M | $8.4M | $10.3M | $12.1M | $12.4M | $14.5M | $16.8M | |||||||
| Assets | $5.1M | $6.3M | $4.6M | $4.2M | $5.0M | $1.7M | $782.6K | $983.6K | $2.6M | $8.5M | $10.4M | $12.2M | $12.4M | $14.5M | $16.8M | |||||||
| Accounts Payable Current | $725.9K | $1.3M | $2.9M | $2.9M | $3.8M | $3.7M | $2.7M | $2.6M | $648.1K | $1.0M | $464.9K | $1.1M | $1.1M | |||||||||
| Liabilities | $717.5K | $983.3K | $634.8K | $725.9K | $1.3M | $2.9M | $4.6M | $3.7M | $2.7M | $2.6M | $1.6M | $1.0M | ||||||||||
| Property Plant And Equipment Net | $370.2K | $397.9K | $425.6K | $228.3K | $241.0K | $253.7K | $189.0K | $201.7K | $214.4K | $85.2K | $90.5K | $95.8K | ||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $1.7M | $817.9K | -$3.4M | -$2.5M | $13.7M | |||||||||||||||||
| Note Receivable For Common Stock Related Party | -$14.9M | -$14.9M | -$14.9M | -$14.9M | -$14.9M | -$14.9M | -$14.9M | -$14.9M | ||||||||||||||
| Liabilities Current | $3.8M | $2.9M | $2.6M | $1.6M | $1.0M | $467.0K | $1.5M | $1.5M | ||||||||||||||
| Amortization Of Debt Discount Premium | $9.3K | $4.8K | ||||||||||||||||||||
| Issuance Of Common Stock For Cash Net Of Issuance Costs | $688.7K | $1.2M | $964.5K | $18.1K | ||||||||||||||||||
| Cash And Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $13.7M | -$27.2K | ||||||||||||||||||||
| Issuance Of Preferred Stock For Cash Net Of Issuance Costs | $4.0M | $5.1M | ||||||||||||||||||||
| Fair Value Of Warrants Issued In Connection With Convertible Notes Payable Related Party | $4.8M | |||||||||||||||||||||
| Convertible Notes Payable | $344.9K | $340.1K | ||||||||||||||||||||
| Preferred Stock Value | ||||||||||||||||||||||
| Issuance Of Common Stock For Related Party Payable | $989.3K | |||||||||||||||||||||
| Gains Losses On Extinguishment Of Debt | $62.4K | |||||||||||||||||||||
| Accounts Payable And Accrued Liabilities Current | $717.5K | $983.3K | $634.8K | |||||||||||||||||||
| Notes Payable Current | ||||||||||||||||||||||
| Issuance Of Preferred Stock For Cash | $2.0M | |||||||||||||||||||||
| Issuance Of Common Stock For Cash | $964.5K | $18.1K | ||||||||||||||||||||
| Fair Value Of Warrants Issued In Connection With Series Convertible Preferred Stock | $510.2K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Share Based Compensation | $325.1K | $955.6K | $3.6M | $4.4M | $2.0M | $1.8M |
| Net Cash Provided By Used In Operating Activities | -$6.6M | -$8.3M | -$8.9M | -$6.6M | -$2.7M | -$2.3M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $149.5K | -$368.4K | $97.9K | -$633.6K | -$260.8K | $15.8K |
| Net Cash Provided By Used In Financing Activities | $10.4M | $3.7M | $200.00 | $18.9M | $4.5M | $2.3M |
| Net Cash Provided By Used In Investing Activities | -$300.0K | -$147.2K | -$106.5K | $100.9K | $105.0K | |
| Proceeds From Issuance Of Common Stock | $2.7M | $1.3M | $6.0M | $2.1M | $2.3M | |
| Increase Decrease In Accounts Payable Trade | $1.7M | $693.6K | -$413.2K | -$175.0K | ||
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$2.3M | $54.9K | $1.7M | |||
| Payments To Acquire Machinery And Equipment | $300.0K | $147.2K | $106.5K | |||
| Proceeds From Stock Options Exercised | $600.00 | $200.00 | $2.2K | |||
| Increase Decrease In Prepaid Expenses Related Party | -$247.3K | -$739.9K | ||||
| Proceeds From Initial Public Offering Net Of Underwriters Discounts And Commissions And Issuance Costs | $12.9M | |||||
| Proceeds From Note Receivable Related Party For Common Stock | $99.9K | $16.8K | ||||
| Proceeds From Issuance Initial Public Offering | $1.5M | |||||
| Proceeds From Collection Of Notes Receivable | $100.9K | $105.0K | ||||
| Proceeds From Notes Payable | $62.1K | |||||
| Proceeds From Note Receivable For Common Stock Related Party | $99.9K | $16.8K | ||||
| Proceeds From Convertible Note Payable Related Party | $50.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q3 2024 | Q3 2023 | Q3 2022 | Q3 2021 | Q4 2020 | Q3 2020 |
|---|---|---|---|---|---|---|---|
| Share Based Compensation | $42.9K | $81.3K | $369.4K | $867.3K | $739.6K | $506.0K | |
| Net Cash Provided By Used In Operating Activities | -$2.4M | -$1.1M | -$3.3M | -$2.5M | -$1.2M | -$205.1K | |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $79.2K | $143.0K | $270.6K | $237.8K | $216.2K | -$346.5K | |
| Net Cash Provided By Used In Financing Activities | $4.0M | $2.0M | $14.9M | $77.0K | |||
| Net Cash Provided By Used In Investing Activities | -$90.0K | -$147.2K | $100.9K | ||||
| Proceeds From Issuance Of Common Stock | $2.0M | ||||||
| Increase Decrease In Accounts Payable Trade | -$136.2K | $569.0K | $173.7K | ||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | $348.6K | -$41.5K | -$129.2K | -$136.2K | |||
| Payments To Acquire Machinery And Equipment | $90.0K | $147.2K | |||||
| Proceeds From Stock Options Exercised | $100.00 | ||||||
| Increase Decrease In Prepaid Expenses Related Party | -$247.3K | ||||||
| Proceeds From Initial Public Offering Net Of Underwriters Discounts And Commissions And Issuance Costs | $12.9M | ||||||
| Proceeds From Note Receivable Related Party For Common Stock | $85.0K | $14.9K | |||||
| Proceeds From Issuance Initial Public Offering | $1.5M | ||||||
| Proceeds From Collection Of Notes Receivable | $100.9K | ||||||
| Proceeds From Notes Payable | $62.1K | ||||||
| Proceeds From Note Receivable For Common Stock Related Party | |||||||
| Proceeds From Convertible Note Payable Related Party | $14.9K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Diluted EPS * | -$11.32 | -$132.33 | -$22.89 | -$0.14 | -$0.07 | -$0.06 |
| Weighted Average Number Of Diluted Shares Outstanding | 450.8K | 74.2K | 650.1K | 89.1M | ||
| Earnings Per Share Basic | $-11.32 | $-132.33 | $-22.89 | $-0.14 | ||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Common Stock Shares Authorized | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Common Stock Shares Outstanding | 76.4K | 646.3K | 95.5M | 67.4M | 64.8M | |
| Weighted Average Number Of Shares Outstanding Basic | 450.8K | 74.2K | 650.1K | 89.1M | 72.7M | |
| Common Stock Shares Issued | 76.4K | 646.3K | 95.5M | 67.4M | 64.8M | |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | |||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 72.7M | 71.3M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.30 | -$1.28 | -$0.19 | -$3.61 | -$11.42 | -$3.77 | -$4.43 | -$5.38 | -$0.83 | -$0.48 | -$0.03 | -$0.03 | -$0.04 | -$0.03 | -$0.02 | -$0.02 | -$0.02 | ||||
| Weighted Average Number Of Diluted Shares Outstanding | 3.4M | 2.1M | 5.5M | 392.4K | 85.3K | 705.4K | 656.4K | 656.3K | 6.6M | 6.5M | 97.5M | 94.2M | 93.5M | 84.6M | |||||||
| Earnings Per Share Basic | $-0.30 | $-1.28 | $-0.19 | $-3.61 | $-11.42 | $-3.77 | $-4.43 | $-5.38 | $-0.83 | $-0.48 | $-0.03 | $-0.03 | $-0.04 | $-0.03 | |||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||
| Common Stock Shares Authorized | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | ||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||
| Common Stock Shares Outstanding | 3.8M | 3.1M | 778.7K | 5.8M | 5.2M | 861.3K | 6.6M | 6.5M | 96.9M | 96.4M | 95.5M | 95.5M | 86.9M | ||||||||
| Weighted Average Number Of Shares Outstanding Basic | 3.4M | 2.1M | 5.5M | 392.4K | 85.3K | 705.4K | 656.4K | 656.3K | 6.6M | 6.5M | 97.5M | ||||||||||
| Common Stock Shares Issued | 3.8M | 3.1M | 778.7K | 5.8M | 5.2M | 861.3K | 6.6M | 6.5M | 96.9M | 96.4M | 95.5M | 95.5M | 90.1M | 88.9M | |||||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | |||||||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 93.5M | 84.6M | 72.3M | 72.3M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Stockbased Compensation To Employees And Consultants | $325.1K | $955.6K | $3.6M | $4.4M | $2.0M | $1.8M |
| Additional Paid In Capital | $51.4M | $62.0M | $57.4M | $33.7M | $27.6M | |
| Costs And Expenses | $14.9M | $12.3M | $5.0M | $4.4M | ||
| Depreciation | $50.7K | $50.7K | $23.1K | $3.5K | ||
| Stock Issued During Period Value Stock Options Exercised | $600.00 | $200.00 | $2.2K | |||
| Due To Related Parties Current | $60.7K | $62.7K | ||||
| Prepaid Expense Current | $247.3K | |||||
| Stock Issued During Period Value New Issues3 | ||||||
| Stock Issued During Period Value New Issues2 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q1 2021 | Q4 2020 | Q3 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockbased Compensation To Employees And Consultants | $31.5K | $42.9K | $81.3K | $81.3K | $81.3K | $186.6K | $318.3K | $369.4K | $1.5M | $715.6K | $867.3K | $1.1M | $1.3M | $739.6K | $489.7K | $483.5K | $506.0K | ||
| Additional Paid In Capital | $66.6M | $66.6M | $62.5M | $60.8M | $60.2M | $53.8M | $49.0M | $62.7M | $62.4M | $61.5M | $59.0M | $58.3M | $52.2M | $50.7M | $49.4M | ||||
| Costs And Expenses | $5.4M | $3.1M | $3.0M | $2.6M | $3.6M | $2.3M | $1.1M | $1.3M | $1.3M | ||||||||||
| Depreciation | $27.7K | $12.7K | $12.7K | $7.1K | |||||||||||||||
| Stock Issued During Period Value Stock Options Exercised | $400.00 | $700.00 | $100.00 | ||||||||||||||||
| Due To Related Parties Current | $989.3K | $2.1K | $2.1K | $2.2K | $60.7K | ||||||||||||||
| Prepaid Expense Current | $494.7K | $742.0K | |||||||||||||||||
| Stock Issued During Period Value New Issues3 | $12.9M | ||||||||||||||||||
| Stock Issued During Period Value New Issues2 | $2.0M |
Most recent annual filing with the SEC: July 22, 2025
Data sourced from SEC EDGAR public filings as of August 5, 2026.